Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation

Area of Science:

• Virology
• Immunology
• Oncology

Background:

• Epstein-Barr virus (EBV) is an oncogenic human herpesvirus infecting B and epithelial cells.
• EBV establishes lifelong latency in memory B cells, with potential for reactivation.
• EBV immortalization of B cells in vitro serves as a model for lymphomagenesis.

Purpose of the Study:

• To summarize recent findings on early EBV gene expression after primary B-cell infection.
• To elucidate the role of transient lytic gene expression in EBV-mediated B-cell transformation.
• To understand how dynamic EBV gene expression controls B-cell activation, cell cycle, apoptosis, and immune responses.

Main Methods:

• Review of recent research characterizing early EBV gene expression.
• Analysis of viral gene expression patterns in primary B-cell infection.
• Comparison of early lytic gene expression with known latency genes.

Main Results:

• Contrary to previous beliefs, EBV exhibits transient early expression of lytic genes upon primary B-cell infection.
• These early lytic genes are essential for efficient B-cell transformation and influence later latency gene expression.
• Dynamic and controlled expression of multiple EBV genes orchestrates B-cell activation, cell cycle entry, apoptosis inhibition, and immune modulation.

Conclusions:

• Early, transient lytic gene expression is a critical, previously underappreciated aspect of EBV's infectious cycle.
• Understanding these early events provides new insights into EBV-driven lymphomagenesis.
• Targeting these early viral activities could offer novel therapeutic strategies against EBV-associated diseases.